Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)
Clinical trial NCT04718467 · WITHDRAWN
Trial details
- NCT number
- NCT04718467
- Sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2021-05-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.